Lymphatic mapping and sentinel node biopsy for melanoma

Expert Review of Anticancer Therapy

Volumn 1, Issue 3, 2001, Pages 446-452

  Thompson, John F ^a   Uren, Roger F ^a  

^a ROYAL PRINCE ALFRED HOSPITAL   (Australia)

Author keywords

Adjuvant therapy; Biopsy; Lymphatic mapping; Melanoma; Prognosis; Sentinel node; Staging

Indexed keywords

ALPHA INTERFERON; ANTIMONY TECHNETIUM SULFIDE TC 99M; DYE; EOSIN; FORMALDEHYDE; HEMATOXYLIN; NANOCOLL TC 99M; TECHNETIUM SULFUR COLLOID TC 99M;

BIOPSY TECHNIQUE; CANCER ADJUVANT THERAPY; CANCER STAGING; CLINICAL STUDY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LYMPH NODE DISSECTION; LYMPHATIC DRAINAGE; LYMPHATIC SYSTEM EXAMINATION; LYMPHOSCINTIGRAPHY; MALE; MEDICAL SPECIALIST; MELANOMA; PREOPERATIVE EVALUATION; RELIABILITY; REVIEW; SENTINEL LYMPH NODE BIOPSY;

EID: 0035560259     PISSN: 14737140     EISSN: None     Source Type: Journal    
DOI: 10.1586/14737140.1.3.446     Document Type: Review

References (52)

1. Elective lymph node dissection in patients with primary melanoma on the trunk and limbs treated at the Sydney Melanoma Unit from 1960 to 1991
2. A prospective randomized study of the efficacy of routine elective lymphadenectomy in management of malignant melanoma
3. Immediate or delayed dissection of regional nodes in patients with melanoma of the trunk: A randomised trial
4. Long-term results of a multi-institutional randomized trial comparing prognostic factors and surgical results for intermediate thickness melanomas (1.0-4.0 mm). Intergroup Melanoma Surgical Trial
5. Interferon α-2b adjuvant therapy of high-risk resected cutaneous melanoma: The Eastern Co-operative Group Trial EST 1684
6. High-dose interferon α-2b significantly prolongs relapse-free and overall survival compared with the GM2-KLH/QS-21 vaccine in patients with resected melanoma: Results of intergroup trial E1694/S9512/C509801
7. High and low-dose interferon α-2b in high-risk melanoma: First analysis of intergroup trial E1690/S9111/C9190
8. Technical details of intraoperative lymphatic mapping for early stage melanoma
9. Lymphoscintigraphy to identify sentinel nodes in patients with melanoma
10. Lymphatic drainage of skin to a sentinel lymph node in a feline model
11. Management of the regional lymph nodes in patients with cutaneous malignant melanoma
12. The orderly progression of melanoma nodal metastases
13. Sentinel lymph node status as an indicator of the presence of metastatic melanoma in regional lymph nodes
14. Validation of the accuracy of intraoperative lymphatic mapping and sentinel lymphadenectomy for early-stage melanoma - A muticenter trial
15. Lymphoscintigraphy in high-risk melanoma of the trunk: Predicting draining node groups, defining lymphatic channels and locating the sentinel node
16. Intraoperative radiolymphoscintigraphy: A useful adjunct to intraoperative lymphatic mapping and selective lymphadenectomy in patients with clinical stage I melanoma
17. Minimal-access surgery for staging of malignant melanoma
18. Single-dose isotope injection for both preoperative lymphoscintigraphy and intraoperative sentinel lymph node identification in melanoma patients
19. Occult tumor cells in the lymph nodes of patients with pathological stage I malignant melanoma. An immunohistological study
20. Surgical pathology of the dye-directed selective lymph node dissection
21. Detection of submicroscopic metastases with polymerase chain reaction in patients with malignant melanoma
22. Molecular Staging of Malignant Melanoma
23. Prognostic significance of occult metastases detected by sentinel lymphadenectomy and reverse transcriptase-polymerase chain reaction in early-stage melanoma patients
24. Long-term follow-up of melanoma patients with sentinel node micrometastases detected by nested RT-PCR for tyrosinase
25. Lymphatic mapping using lymphoscintigraphy
26. Patterns of lymphatic drainage of the skin
27. The location of the sentinel lymph node in cutaneous melanoma: New insights into lymphatic anatomy
28. Lymphatic drainage to triangular intermuscular space lymph nodes in melanoma on the back
29. Lymphatic drainage from the skin of the back to retroperitoneal and paravertebral lymph nodes in melanoma patients
30. New route for metastatic spread of melanoma?
31. Exclusive lymphatic drainage from a melanoma on the back to intra-abdominal lymph nodes
32. Lymphatic drainage from peri-umbilical skin to internal mammary nodes
33. Contralateral groin node metastasis from lower limb melanoma
34. Direct lymph node drainage from the skin of the elbow to an interpectoral node
35. Direct lymphatic drainage from the skin of the forearm to a supraclavicular node
36. Interval nodes: The forgotten sentinel nodes in patients with melanoma
37. Epitrochlear lymph nodes as a site of melanoma metastasis
38. Popliteal lymph node metastasis from primary cutaneous melanoma
39. Failure to detect drainage to the popliteal and epitrochlear lymph nodes on cutaneous lymphoscintigraphy in melanoma patients
40. Sentinel lymph node biopsy for melanoma
41. Surgical management of occult lymph node metastases
42. Lymphatic mapping and selective lymphadenectomy for melanoma: Not yet standard therapy
43. What is a 'sentinel' lymph node?
44. The argument against sentinel node biopsy for malignant melanoma
45. Time and frequency of recurrence of cutaneous stage I malignant melanoma: Guidelines for follow-up
46. Sentinel lymph node biopsy in the management of patients with primary cutaneous melanoma: Review of a large single-institutional experience with an emphasis on recurrence
47. Will the true sentinel node please stand?
48. Patterns of recurrence following a negative sentinel lymph node biopsy in 243 patients with stage I or II melanoma
49. Outcome of patients with melanoma and histologically negative sentinel lymph nodes
50. Efficacy of lymphatic mapping, sentinel lymphadenectomy and selective complete lymph node dissection as a therapeutic procedure for early-stage melanoma
51. Reliability of the sentinel node procedure in melanoma patients: Analysis of failures after long-term follow-up
52. γ-Probe guided biopsy of the sentinel node in malignant melanoma: A multicentre study